Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Volume

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on May 26, 2021 3:47pm

77 Views

Post# 33269443

RE:RE:Volume

It's really gone backward with average daily volume in the last month. So much for replacing our tiny spigot with something bigger to make it more attractive to traders or larger investors. Pretty disturbing development from a technical perspective. No easy fix to turn that around except some outstanding data on trials or revenues. Was hoping it would start to trend higher on decent volume into June/July for some data readouts sometime in July.

stockman75 wrote:

jeffm34 wrote: After 5 hours of trading the volume on TSX is 7000 shares traded

Good thing our THTX is working so hard on investor relations and getting the story out or we would be at 10 or 20 shares.. LOL.